On the one hand, survival analysis, clinical feature analysis, univariate/multivariate regression analysis, and GSEA were used to study NAP1L1 by collecting HCC patients from GSE14520, GSE76427, ICGC, and TCGA. This evidence concerns the gene NAP1L1 and hepatocellular carcinoma.